MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
![Foto de MIGUEL JOSÉ](/img/nophoto.png)
![Foto de Institute of Oncology Ljubljana](/img/noimage_org.png)
Institute of Oncology Ljubljana
Liubliana, EsloveniaPublications en collaboration avec des chercheurs de Institute of Oncology Ljubljana (3)
2022
-
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population (Breast Cancer Research and Treatment, (2021), 189, 3, (689-699), 10.1007/s10549-021-06334-0)
Breast Cancer Research and Treatment
2021
-
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
Breast Cancer Research and Treatment, Vol. 189, Núm. 3, pp. 689-699
2013
-
The evolving landscape of protein kinases in breast cancer: Clinical implications
Cancer Treatment Reviews, Vol. 39, Núm. 1, pp. 68-76